Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsies

References

1. Barbosa M. S., Schlegel R. 1989; The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529–1532
   [Google Scholar]
2. Bosch F. X., Lorincz A., Muñoz N., Meijer C. J. L. M., Shah K. V. 2002; The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265 [CrossRef]
   [Google Scholar]
3. Crook T., Morgenstern J. P., Crawford L., Banks L. 1989; Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ- ras . EMBO J 8:513–519
   [Google Scholar]
4. Dyson N., Howley P. M., Munger K., Harlow E. 1989; The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937 [CrossRef]
   [Google Scholar]
5. Fiedler M., Müller-Holzner E., Viertler H.-P., Widschwendter A., Laich A., Pfister G., Spoden G. A., Jansen-Dürr P., Zwerschke W. 2004; High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J 18:1120–1122
   [Google Scholar]
6. Geisbill J., Osmers U., Dürst M. 1997; Detection and characterization of human papillomavirus type 45 DNA in the cervical carcinoma cell line MS751. J Gen Virol 78:655–658
   [Google Scholar]
7. Hudson J. B., Bedell M. A., McCance D. J., Laiminis L. A. 1990; Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64:519–526
   [Google Scholar]
8. Jeon S., Allen-Hoffmann B. L., Lambert P. F. 1995; Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989–2997
   [Google Scholar]
9. Klaes R., Friedrich T., Spitkovsky D., Ridder R., Rudy W., Petry U., Dallenbach-Hellweg G., Schmidt D., von Knebel Doeberitz M. 2001; Overexpression of p16^INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284 [CrossRef]
   [Google Scholar]
10. Lowy D. R., Howley P. M. 2001; Papillomaviruses. In Field's Virology , 4th edn. pp  2231–2264 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
11. Luft F., Klaes R., Nees M., Dürst M., Heilmann V., Melsheimer P., von Knebel Doeberitz M. 2001; Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92:9–17 [CrossRef]
    [Google Scholar]
12. Mannhardt B., Weinzimer S., Wagner M., Fiedler M., Cohen P., Jansen-Dürr P., Zwerschke W. 2000; Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 20:6483–6495 [CrossRef]
    [Google Scholar]
13. Münger K., Howley P. M. 2002; Human papillomavirus immortalization and transformation functions. Virus Res 89:213–228 [CrossRef]
    [Google Scholar]
14. Münger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. 1989; The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417–4421
    [Google Scholar]
15. Muñoz N. 2000; Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5 [CrossRef]
    [Google Scholar]
16. Pisani P., Bray F., Parkin D. M. 2002; Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72–81 [CrossRef]
    [Google Scholar]
17. Sano T., Oyama T., Kashiwabara K., Fukuda T., Nakajima T. 1998; Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153:1741–1748 [CrossRef]
    [Google Scholar]
18. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114 [CrossRef]
    [Google Scholar]
19. Smotkin D., Wettstein F. O. 1987; The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61:1686–1689
    [Google Scholar]
20. Ullman C. G., Haris P. I., Galloway D. A., Emery V. C., Perkins S. J. 1996; Predicted α -helix/ β -sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. Biochem J 319:229–239
    [Google Scholar]
21. von Knebel Doeberitz M. 2002; New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38:2229–2242 [CrossRef]
    [Google Scholar]
22. Walboomers J. M. M., Jacobs M. V., Manos M. M. 7 other authors 1999; Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19 [CrossRef]
    [Google Scholar]
23. zur Hausen H. 2000; Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690–698 [CrossRef]
    [Google Scholar]
24. Zwerschke W., Jansen-Dürr P. 2000; Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78:1–29
    [Google Scholar]